“Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital” (2020) Indian Journal of Forensic Medicine & Toxicology, 14(2), pp. 2505–2510. doi:10.37506/ijfmt.v14i2.3485.